Filing Flows › Companies › Capricor Therapeutics › Report card
Capricor Therapeutics earnings report card
Every report on file against what analysts and the company itself expected, and what the stock did
Beat rate1 of 3 reports beat the EPS estimate
Capricor Therapeutics (CAPR) beat the analysts' EPS estimate in 1 of its last 3 reports (33%), by -11.3% on average. Next report: Nov 10, 2026, analysts expect EPS −$0.41.
Beat rate33% of 3
Average surprise-11.3%
Next reportNov 10, 2026
Report by report
| Quarter | Reported | EPS est. | EPS reported | Surprise |
|---|---|---|---|---|
| Q to Jun 2026 | Aug 13, 2026 | −$0.58 | −$0.70 | -21.6% |
| Q to Dec 2025 | Mar 12, 2026 | −$0.55 | −$0.62 | -12.4% |
| Q to Sep 2025 | Nov 10, 2025 | −$0.54 | −$0.54 | +0.3% |
Estimates and reported EPS are the Street's adjusted figures. No daily prices are on file for these report days, so the stock's moves are not shown.
Charts
The next report: what to expect → Capricor Therapeutics: every quarter →
Read automatically from SEC filings, earnings releases and public estimates; errors are possible. Not investment advice.